Header cover image

Polish Biotech Stocks

Results

7

0 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

7 companies

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.

CLN

zł20.50

7D

-2.1%

1Y

-6.8%

Selvita

Market Cap: zł549.7m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł29.95

7D

0.3%

1Y

-0.8%

Ryvu Therapeutics

Market Cap: zł381.5m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł16.50

7D

-8.3%

1Y

-45.1%

Biogened

Market Cap: zł45.7m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł18.60

7D

0%

1Y

-39.2%

Genomed Spólka Akcyjna

Market Cap: zł32.0m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł24.20

7D

0.8%

1Y

-1.6%

Stem Cells Spin

Market Cap: zł14.9m

Operates as a biotechnology company in Poland.

SCS

zł0.36

7D

-10.0%

1Y

103.4%

Labocanna

Market Cap: zł4.4m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.21

7D

-0.9%

1Y

-35.5%